Regulation

Reform

The landscape of alternative therapies like CBD, ketamine, and psilocybin is experiencing significant reform globally. CBD, derived from cannabis, has ...

October 2, 2024

What It Means for Healthcare Providers

As ketamine gains recognition for its potential in treating conditions like treatment-resistant depression (TRD), post-traumatic stress disorder (PTSD), and chronic ...

July 15, 2024

What It Means for Patients

Ketamine, once primarily known as an anesthetic, has emerged as a promising treatment for conditions like treatment-resistant depression, chronic pain, ...

May 22, 2024

VitalPoint Technologies, Inc.

Disclaimer

None of the statements in this announcement or via any web sites linked herein have been evaluated by the FDA. Furthermore, none of the statements in this announcement or any web sites linked herein should be construed as dispensing medical advice or making claims regarding the cure of diseases. You should consult a licensed health care professional before starting any supplement, dietary, or exercise program, especially if you are pregnant or have any pre-existing injuries or medical conditions. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any diseases.